Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration - Ophthalmology

Department of Clinical Medicine

Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration

Research output: Contribution to journal › Journal article › Research › peer-review

Documents

Real-world 10-year experiences with intravitreal treatment with ranibizumab and aflibercept for neovascular age-related macular degeneration_(accepted_version)
Accepted author manuscript, 289 KB, PDF document

Troels Brynskov
Inger Christine Munch
Tobias Larsen
Liv Erngaard
Sørensen, Torben Lykke

Original language	English
Journal	Acta Ophthalmologica
Volume	98
Issue number	2
Pages (from-to)	132-138
ISSN	1755-375X
DOIs	https://doi.org/10.1111/aos.14183
Publication status	Published - 2020

ID: 222095444